Macao suspends inoculation of mRNA COVID-19 vaccines made in Germany due to package flaw
MACAO -- China's Macao Special Administrative Region on Wednesday suspended inoculation of mRNA COVID-19 vaccines made in Germany due to package flaws related to the vial tops, according to the Novel Coronavirus Response and Coordination Center of the Macao SAR.
An investigation has been launched into the cause of the problem by BioNTech and Fosun Pharma, developers of the vaccine, according to the center.
The developers so far do not have the reason to believe the vaccines have safety risks and the suspension of inoculation during the investigation is out of caution, said the center.
Local residents who have made reservations for inoculation of the vaccine do not need to visit inoculation facilities until further notice, the center said.
The first batch of mRNA vaccines were delivered to Macao on Feb 27. Inoculation started on March 3.
- China opens draft regulations on data protection to public consultation
- Veteran French physicist elected to Chinese Academy of Sciences
- Former Polish deputy PM praises China's economic rise, growing influence
- HK powers the nation's equestrian development
- Forum hailed for promoting Global South modernization
- Wushu needs more events in GBA, coaches in Macao say































